These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29282042)

  • 1. Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.
    Liu B; Wan Z; Sheng B; Lin Y; Fu T; Zeng Q; Qi C
    BMC Pulm Med; 2017 Dec; 17(1):214. PubMed ID: 29282042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between loss of Smad4 and clinical parameters of non-small cell lung cancer: an observational cohort study.
    Guo X; Li M; Wang X; Pan Y; Li J
    BMC Pulm Med; 2021 Apr; 21(1):111. PubMed ID: 33794845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased stathmin correlates with advanced stage and poor survival of non-small cell lung cancer.
    Rong B; Nan Y; Liu H; Gao W
    Cancer Biomark; 2017; 19(1):35-43. PubMed ID: 28282798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of IRAK1 in lung cancer tissues and its clinicopathological significance: a microarray study.
    Zhang X; Dang Y; Li P; Rong M; Chen G
    Int J Clin Exp Pathol; 2014; 7(11):8096-104. PubMed ID: 25550857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
    Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
    Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of liver kinase B1 and Beclin1 is associated with the poor survival of patients with non-small cell lung cancer.
    Jiang L; Liang X; Liu M; Wang W; Ma J; Guo Q; Han L; Yang C; Nan K
    Oncol Rep; 2014 Nov; 32(5):1931-8. PubMed ID: 25175672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis.
    Takanami I
    Int J Cancer; 2003 Jun; 105(2):186-9. PubMed ID: 12673677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical and prognostic significance of YWHAZ in non-small-cell lung cancer patients: Immunohistochemical analysis.
    Deng Y; Zheng J; Ma J
    J Cell Biochem; 2019 Apr; 120(4):6290-6298. PubMed ID: 30378158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer.
    Luo J; Song J; Feng P; Wang Y; Long W; Liu M; Li L
    Tumour Biol; 2016 Aug; 37(8):10715-21. PubMed ID: 26873483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New P16 Expression Criteria Predict Lymph Node Metastasis in Patients With Non-small Cell Lung Cancer.
    An HJ; Koh HM; Song DH
    In Vivo; 2019; 33(6):1885-1892. PubMed ID: 31662516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer.
    Chen Y; Jiang H; Zhu L; Wang P; Liu S; Xiao X; Yu H; Dong W
    Clin Lab; 2017 Jan; 63(1):59-65. PubMed ID: 28164488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF receptor-associated factor 1 as a biomarker for assessment of non-small cell lung cancer metastasis and overall survival.
    Wen X; Wang B; Feng T; Yuan W; Zhou J; Fang T
    Clin Respir J; 2018 Jul; 12(7):2197-2203. PubMed ID: 29528567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.
    Bi MM; Shang B; Wang Z; Chen G
    Thorac Cancer; 2017 Nov; 8(6):634-641. PubMed ID: 28925100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
    Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
    Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of AKT2, cyclin D1, and MMP-9 and their correlations to clinicopathologic features of non-small cell lung cancer].
    Wang J; Miao LJ; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Jan; 25(1):69-72. PubMed ID: 16405753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.